Physician profile
Anthony E Ackerman
NPI 1700093630
$3,107.30
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $220 · 2021: $594 · 2022: $677 · 2023: $1,245 · 2024: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.02 | 2021-2023 | Qulipta, Ubrelvy, Botox |
| E.R. Squibb & Sons, L.L.C. | $545.62 | 2021-2023 | Zeposia |
| Teva Pharmaceuticals USA, INC. | $364.30 | 2019-2021 | |
| Lundbeck LLC | $283.31 | 2023 | Vyepti |
| Sk Life Science, INC. | $268.37 | 2020-2023 | Xcopri |
| Biohaven Pharmaceuticals, INC. | $234.96 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $176.21 | 2022 | |
| Impel Pharmaceuticals INC. | $144.00 | 2022 | |
| Sunovion Pharmaceuticals INC. | $120.38 | 2019 | |
| Bioventus LLC | $86.20 | 2024 | None |
| Boston Scientific Corporation | $26.93 | 2024 | Bionic Navigator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.